CLENBUTERLIN 60

Description

Indications and usages:
Rapid restore muscle tissue atrophied during recovery from a traumatic injury. Offset muscle catabolism in patients with a wasting syndrome Treat certain types of anemia which are non-responsive to first line agents.

Contraindications:

The use of CLENBUTERLIN 10 is contraindicated in the following: Not indicated for women, children, or the elderly. Patient with diagnosed or suspected male breast carcinoma or carcinoma of the prostate. Patient with diagnosed or suspected female breast carcinoma with hypercalcemia as androgenic agents may increase osteolytic bone resorption. Women who are pregnant or may become pregnant because of possible masculinisation of the fetus. Patient with hypercalcemina. Patient with preexisting cardiac, renal, and/or hepatic disease. This product is hepatotoxic and requires hepatic monitoring, discontinue if any compound presents.

Drug interactions:

Oral hypoglycaemic agents: may inhibit the metabolism of oral hypoglycaemic agents which may require adjustments of dosage. Anti coagulants: Patients on anticoagulants should be carefully monitored during anabolic steroid therapy as anabolic steroids may increase sensitivity towards anticoagulants. Patients should be monitored regularly during anabolic steroid therapy, particularly during initiation and termination of therapy.

Side effects/adverse reactions”

Men:
Prepubertal: phallic enlargement, increased frequency of erections. Postpubertal: inhibition of testicular function, oligospermia, gynecomastica

Women:
Hirsutism male pattern baldness; deepening of the voice; clitorol enlargement. These changes are usually irreversible even after prompt discontinue of therapy and are not prevented by consomitant use of estrogens. In additon, the following may occur: menstrual irregularities; masculinisation of the fetus.

Overdosage:

Signs and symptoms of overdosage are those associated with the known effects of the drug. See adverse reactions section.
Treatment is symptomatic and supportive. Evacuate stomach contents by emesis and, if indicated, revise taking care to prevent aspiration. Monitoring of liver function is advised